Clinical use of C-reactive protein for cardiovascular disease

Area of Science:

• Biomedical Science
• Clinical Medicine
• Preventive Cardiology

Background:

• Growing evidence links elevated inflammatory markers, including C-reactive protein, to increased cardiovascular disease (CVD) risk.
• Inflammatory markers are associated with conditions like diabetes, obesity, and hypertension, highlighting their importance in chronic disease management.
• The American Heart Association issued guidelines in 2003 for using these markers in clinical practice.

Purpose of the Study:

• To review the 2003 American Heart Association guidelines on inflammatory markers for cardiovascular disease risk.
• To synthesize recent evidence published after the 2003 guidelines regarding inflammation's role in cardiovascular risk.
• To provide evidence-based recommendations for primary care practitioners on utilizing inflammatory markers in clinical practice.

Main Methods:

• Literature review of studies published before and after the 2003 American Heart Association guidelines.
• Analysis of recent reviews and original research on inflammation and cardiovascular risk.
• Synthesis of findings to inform clinical practice recommendations.

Main Results:

• Inflammation, indicated by markers like C-reactive protein, is increasingly recognized as a significant factor in cardiovascular disease.
• Post-guideline studies further corroborate the association between inflammatory markers and CVD.
• The role of inflammation is crucial for both prevention and management of chronic diseases.

Conclusions:

• Inflammatory markers are valuable tools in assessing cardiovascular disease risk.
• Primary care clinicians should be aware of the latest evidence and guidelines regarding inflammatory markers.
• Integrating knowledge of inflammation into clinical practice can enhance chronic disease prevention and management strategies.